Commercial Research Funding Opportunity
This grant funds companies advancing innovative MS therapies or technologies from research toward commercialization to address unmet needs in multiple sclerosis.
Funder: National Multiple Sclerosis Society
Due Dates (Anticipated): June 2026 (Full application deadline, projected)
Funding Amounts: Award size and duration vary; typically supports advancement of commercial MS therapies and technologies.
Summary: Supports companies developing innovative therapies and technologies for multiple sclerosis, advancing research toward commercialization.
Description
This funding opportunity is designed to accelerate the development and commercialization of innovative therapies, technologies, or products that address unmet needs in multiple sclerosis (MS). It targets companies and commercial entities aiming to move promising MS research projects toward practical application, bridging the gap between scientific discovery and real-world solutions for people living with MS. The grant provides both financial support and strategic guidance to help bring new treatments and technologies closer to market.
